Comments
Shares of Alkem Labs today went up by over 5 per cent after the company said one of its manufacturing plants in Gujarat has obtained establishment approval from US health regulator USFDA.
The stock had climbed 4.91 per cent to Rs 1,377.75 on the BSE. On the NSE, it had soared 5.16 per cent to Rs 1,379.
At about 2 pm, Alkem shares were up 2.08 per cent or Rs 27.25 at Rs 1,340.50 on the BSE.
“Its manufacturing plant at Mandva, Gujarat, has successfully obtained the Establishment Inspection Report from the USFDA. The plant manufactures Active Pharmaceutical Ingredients (APIs) and was inspected by the USFDA in September 2015,” Alkem Labs said in a BSE filing yesterday.
It further said: “The facility at Mandva would be Alkem’s sixth plant to receive USFDA approval.”
“The development re—affirms Alkem’s focus towards US as its key market and further boost Alkem’s ability to enhance its product offering in the market,” Alkem Labs CEO Prabhat Aggarwal said.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.